Protein Misfolding and ER Stress in Huntington's Disease

被引:76
作者
Shacham, Talya [1 ,2 ]
Sharma, Neeraj [1 ,2 ]
Lederkremer, Gerardo Z. [1 ,2 ]
机构
[1] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, George Wise Fac Life Sci, Tel Aviv, Israel
基金
以色列科学基金会;
关键词
Huntington's disease; neurodegeneration; protein misfolding; protein aggregation; ER stress; unfolded protein response; ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK PROTEINS; SIGMA-1; RECEPTOR; MUTANT HUNTINGTIN; MOUSE MODEL; TRANSCRIPTION FACTOR; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; CAENORHABDITIS-ELEGANS;
D O I
10.3389/fmolb.2019.00020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence in recent years indicates that protein misfolding and aggregation, leading to ER stress, are central factors of pathogenicity in neurodegenerative diseases. This is particularly true in Huntington's disease (HD), where in contrast with other disorders, the cause is monogenic. Mutant huntingtin interferes with many cellular processes, but the fact that modulation of ER stress and of the unfolded response pathways reduces the toxicity, places these mechanisms at the core and gives hope for potential therapeutic approaches. There is currently no effective treatment for HD and it has a fatal outcome a few years after the start of symptoms of cognitive and motor impairment. Here we will discuss recent findings that shed light on the mechanisms of protein misfolding and aggregation that give origin to ER stress in neurodegenerative diseases, focusing on Huntington's disease, on the cellular response and on how to use this knowledge for possible therapeutic strategies.
引用
收藏
页数:12
相关论文
共 196 条
  • [1] Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation
    Abisambra, Jose F.
    Jinwal, Umesh K.
    Blair, Laura J.
    O'Leary, John C., III
    Li, Qingyou
    Brady, Sarah
    Wang, Li
    Guidi, Chantal E.
    Zhang, Bo
    Nordhues, Bryce A.
    Cockman, Matthew
    Suntharalingham, Amirthaa
    Li, Pengfei
    Jin, Ying
    Atkins, Christopher A.
    Dickey, Chad A.
    [J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (22) : 9498 - 9507
  • [2] RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA
    Aguiar, Sebastian
    van der Gaag, Bram
    Cortese, Francesco Albert Bosco
    [J]. TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [3] A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits
    Aharony, Israel
    Ehrnhoefer, Dagmar E.
    Shruster, Adi
    Qiu, Xiaofan
    Franciosi, Sonia
    Hayden, Michael R.
    Offen, Daniel
    [J]. HUMAN MOLECULAR GENETICS, 2015, 24 (09) : 2604 - 2614
  • [4] A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
    Al-Saif, Amr
    Al-Mohanna, Futwan
    Bohlega, Saeed
    [J]. ANNALS OF NEUROLOGY, 2011, 70 (06) : 913 - 919
  • [5] Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease
    Arnoux, Isabelle
    Willam, Michael
    Griesche, Nadine
    Krummeich, Jennifer
    Watari, Hirofumi
    Offermann, Nina
    Weber, Stephanie
    Dey, Partha Narayan
    Chen, Changwei
    Monteiro, Olivia
    Buettner, Sven
    Meyer, Katharina
    Bano, Daniele
    Radyushkin, Konstantin
    Langston, Rosamund
    Lambert, Jeremy J.
    Wanker, Erich
    Methner, Axel
    Krauss, Sybille
    Schweiger, Susann
    Stroh, Albrecht
    [J]. ELIFE, 2018, 7
  • [6] mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
    Ast, Anne
    Buntru, Alexander
    Schindler, Franziska
    Hasenkopf, Regine
    Schulz, Aline
    Brusendorf, Lydia
    Klockmeier, Konrad
    Grelle, Gerlinde
    McMahon, Benjamin
    Niederlechner, Hannah
    Jansen, Isabelle
    Diez, Lisa
    Edel, Juliane
    Boeddrich, Annett
    Franklin, Sophie A.
    Baldo, Barbara
    Schnoegl, Sigrid
    Kunz, Severine
    Purfuerst, Bettina
    Gaertner, Annette
    Kampinga, Harm H.
    Morton, A. Jennifer
    Petersen, Asa
    Kirstein, Janine
    Bates, Gillian P.
    Wanker, Erich E.
    [J]. MOLECULAR CELL, 2018, 71 (05) : 675 - +
  • [7] Effect of fetal neural transplants inpatients with Huntington's disease 6 years after surgery:: a long-term follow-up study
    Bachoud-Lévi, AC
    Gaura, V
    Brugières, P
    Lefaucheur, JP
    Boissé, MF
    Maison, P
    Baudic, S
    Ribeiro, MJ
    Bourdet, C
    Remy, P
    Cesaro, P
    Hantraye, P
    Peschanski, M
    [J]. LANCET NEUROLOGY, 2006, 5 (04) : 303 - 309
  • [8] In vivo aspects of protein folding and quality control
    Balchin, David
    Hayer-Hartl, Manajit
    Hartl, F. Ulrich
    [J]. SCIENCE, 2016, 353 (6294)
  • [9] Stimulation of Sigma Receptors with Afobazole Blocks Activation of Microglia and Reduces Toxicity Caused by Amyloid-β25-35
    Behensky, Adam A.
    Yasny, Ilya E.
    Shuster, Alexander M.
    Seredenin, Sergei B.
    Petrov, Andrey V.
    Cuevas, Javier
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 347 (02) : 458 - 467
  • [10] Global changes to the ubiquitin system in Huntington's disease
    Bennett, Eric J.
    Shaler, Thomas A.
    Woodman, Ben
    Ryu, Kwon-Yul
    Zaitseva, Tatiana S.
    Becker, Christopher H.
    Bates, Gillian P.
    Schulman, Howard
    Kopito, Ron R.
    [J]. NATURE, 2007, 448 (7154) : 704 - U11